Wang W - Search Results

1

A novel "mosaic-type" nanoparticle for selective drug release targeting hypoxic cancer cells.

Wang W , Li X , Wang Z , Zhang J , Dong X , Wu Y , Fang C , Zhou A , Wu Y . Wang W , et al. Among authors: wang z. Nanoscale. 2019 Jan 31;11(5):2211-2222. doi: 10.1039/c8nr06452k. Nanoscale. 2019. PMID: 30656317

2

Redox- and light-responsive alginate nanoparticles as effective drug carriers for combinational anticancer therapy.

Zhang C, Shi G, Zhang J, Niu J, Huang P, Wang Z, Wang Y, Wang W, Li C, Kong D. Zhang C, et al. Among authors: wang w, wang z, wang y. Nanoscale. 2017 Mar 2;9(9):3304-3314. doi: 10.1039/c7nr00005g. Nanoscale. 2017. PMID: 28225139

3

NO prodrug-conjugated, self-assembled, pH-responsive and galactose receptor targeted nanoparticles for co-delivery of nitric oxide and doxorubicin.

Zhang J , Song H , Ji S , Wang X , Huang P , Zhang C , Wang W , Kong D . Zhang J , et al. Among authors: wang x, wang w. Nanoscale. 2018 Mar 1;10(9):4179-4188. doi: 10.1039/c7nr08176f. Nanoscale. 2018. PMID: 29442103

4

Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid.

Chen X, Zhang X, Cai H, Yang W, Lei H, Xu H, Wang W, Zhu Q, Kang J, Yin T, Gu W, Wu YL. Chen X, et al. Among authors: wang w. Cancer Lett. 2020 Jan 28;469:277-286. doi: 10.1016/j.canlet.2019.10.015. Epub 2019 Oct 9. Cancer Lett. 2020. PMID: 31605775

5

Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery.

Lou S, Gao S, Wang W, Zhang M, Zhang J, Wang C, Li C, Kong D, Zhao Q. Lou S, et al. Among authors: wang w, wang c. Nanoscale. 2015 Feb 21;7(7):3137-46. doi: 10.1039/c4nr06714b. Nanoscale. 2015. PMID: 25613320

6

An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform.

Wang W, Song H, Zhang J, Li P, Li C, Wang C, Kong D, Zhao Q. Wang W, et al. Among authors: wang c. J Control Release. 2015 Apr 10;203:57-66. doi: 10.1016/j.jconrel.2015.02.015. Epub 2015 Feb 12. J Control Release. 2015. PMID: 25683618

7

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer.

Zhang Y, Yang C, Wang W, Liu J, Liu Q, Huang F, Chu L, Gao H, Li C, Kong D, Liu Q, Liu J. Zhang Y, et al. Among authors: wang w. Sci Rep. 2016 Feb 15;6:21225. doi: 10.1038/srep21225. Sci Rep. 2016. PMID: 26876480 Free PMC article.

8

Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.

Shi GN, Zhang CN, Xu R, Niu JF, Song HJ, Zhang XY, Wang WW, Wang YM, Li C, Wei XQ, Kong DL. Shi GN, et al. Biomaterials. 2017 Jan;113:191-202. doi: 10.1016/j.biomaterials.2016.10.047. Epub 2016 Oct 29. Biomaterials. 2017. PMID: 27816821 Free article.

9

Engineering biodegradable guanidyl-decorated PEG-PCL nanoparticles as robust exogenous activators of DCs and antigen cross-presentation.

Li P, Song H, Zhang H, Yang P, Zhang C, Huang P, Kong D, Wang W. Li P, et al. Among authors: wang w. Nanoscale. 2017 Sep 21;9(36):13413-13418. doi: 10.1039/c7nr04470d. Nanoscale. 2017. PMID: 28876002

10

Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.

Zhao J, Yan C, Chen Z, Liu J, Song H, Wang W, Liu J, Yang N, Zhao Y, Chen L. Zhao J, et al. Among authors: wang w. J Colloid Interface Sci. 2019 Mar 22;540:66-77. doi: 10.1016/j.jcis.2019.01.021. Epub 2019 Jan 7. J Colloid Interface Sci. 2019. PMID: 30634060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87,768 results

Search Page

Filters